-
Product Insights
N-Formyl Peptide Receptor 2 – Drugs In Development, 2023
Global Markets Direct’s N-Formyl Peptide Receptor 2 provides in depth analysis on N-Formyl Peptide Receptor 2 targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in N-Formyl Peptide Receptor...
-
Product Insights
N Myc Proto Oncogene Protein – Drugs In Development, 2023
Global Markets Direct’s N Myc Proto Oncogene Protein provides in depth analysis on N Myc Proto Oncogene Protein targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in N...
-
Product Insights
Histone Lysine N Methyltransferase EZH1 – Drugs In Development, 2023
Global Markets Direct’s Histone Lysine N Methyltransferase EZH1 provides in depth analysis on Histone Lysine N Methyltransferase EZH1 targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in Histone...
-
Product Insights
UDP-3-O-[3-Hydroxymyristoyl] N-Acetylglucosamine Deacetylase – Drugs In Development, 2023
Global Markets Direct’s UDP-3-O-[3-Hydroxymyristoyl] N-Acetylglucosamine Deacetylase provides in depth analysis on UDP-3-O-[3-Hydroxymyristoyl] N-Acetylglucosamine Deacetylase targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in UDP-3-O-[3-Hydroxymyristoyl] N-Acetylglucosamine Deacetylase targeted therapeutics...
-
Sector Analysis
NewHER2-Positive Breast Cancer Epidemiology Analysis and Forecast to 2033
Breast cancer (International Classification of Diseases, 10th Revision [ICD-10] codes C50.0–50.9) is a malignant tumor that originates in the breast tissue. Breast cancer cells begin inside the milk ducts of the breast. The earliest form (in situ) is not life-threatening and can be detected in early stages. The most common type of non-invasive (stage 0) types of breast cancer is called ductal carcinoma in situ (DCIS) (American Cancer Society, 2022; World Health Organization, 2024). DCIS refers to abnormal cells that...
-
Sector Analysis
NewMethicillin-Resistant Staphylococcus aureus (MRSA) Epidemiology Analysis and Forecast to 2033
Methicillin-Resistant Staphylococcus aureus (MRSA) Report Overview In the 7MM, there were 714,131 hospitalized incident cases of Methicillin-Resistant Staphylococcus aureus (MRSA) in 2023. The hospitalized incident cases of Methicillin-Resistant Staphylococcus aureus (MRSA) will register an AGR of more than 1% during 2023-2033. Methicillin-resistant Staphylococcus aureus (MRSA) is a virulent, antibiotic-resistant bacteria that is associated with considerable morbidity and mortality. MRSA can be categorized according to the setting in which the infection was acquired, as either healthcare-associated MRSA (HA-MRSA), which is acquired...
-
Product Insights
N & L Slope Mine
The N & L Slope Mine is a coal mine in United States. It is currently in operation. Empower your strategies with our N & L Slope Mine report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and...
-
Product Insights
N. Manzoor Ahmed Mine
The N. Manzoor Ahmed Mine is a iron ore mine in India. It is currently in operation. Empower your strategies with our N. Manzoor Ahmed Mine report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Reasons...
-
Product Insights
Wind Park N 1
Wind Park N 1 is an Onshore Wind project located in Leningrad, Russia. The project is owned and being developed by WES Sviritsa LLC. The project is at the permitting stage. Empower your strategies with our Wind Park N 1 report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of...
-
Product Insights
NewLikelihood of Approval Analysis for Neisseriaceae Infections
Overview How likely is it that the drugs in Neisseriaceae Infections will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Neisseriaceae Infections Overview The Neisseriaceae family encompasses a group of bacteria, including...